Skip to main content

Table 1 Clinical characteristics

From: Endoscopic vacuum therapy for postoperative esophageal leak

Variables

Patients (n = 20)

Male

20 (100.0)

Age, years

66.5 (53–77)

WBC, ×103/uL

8.59 (5.59–17.48)

CRP, mg/dL

6.85 (0.58–26.74)

Organ failure

2 (10.0)

CCI score

 0

14 (70.0)

 1–3

6 (30.0)

Neoadjuvant treatment

  No

10 (50.0)

  Yes

10 (50.0)

Operation

 Ivor-Lewis operation

7 (35.0)

 3-field lymph node dissection

8 (40.0)

 McKeown operation

4 (20.0)

 Transhiatal esophagectomy

1 (5.0)

Anastomosis

 Intrathoracic anastomosis

13 (65.0)

 Cervical anastomosis

7 (35.0)

Anastomotic leak

 Time to diagnosis, days

12.5 (5–35)

 Fistula size, cm

1.75 (0.5–3.0)

 Mucosal ischemia on EGD

16 (80.0)

EVAC treatment

 Time to treatment, days

3 (0–24)

 Duration of EVAC, days

14.5 (4–56)

 Number of interventions

5 (2–12)

 Treatment failure

1 (5.0)

Hospital stay, days

49 (19–90)

Mortality

1 (5.0)

  1. WBC white blood cell, CRP C-reactive protein, CCI Charlson comorbidity index, EGD esophagoduodenoscopy, EVAC endoscopic vacuum-assisted closure
  2. Data are shown as the median with range or number (%) of patients